Denosumab stalls skeletal-related events in breast ca: Time to a first event was 5 months longer than with zoledronic acid and to hypercalcemia, 7 months - Commentary

Charles L. Loprinzi

Denosumab stalls skeletal-related events in breast ca: Time to a first event was 5 months longer than with zoledronic acid and to hypercalcemia, 7 months - Commentary

Medical Oncology

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	43
Number of pages	1
Journal	Oncology Report
Issue number	JANUARY
State	Published - Jan 2011

ASJC Scopus subject areas

Hematology
Oncology

Cite this

@article{3f301432a1d34a34a2ab78ff72e8b4c3,

title = "Denosumab stalls skeletal-related events in breast ca: Time to a first event was 5 months longer than with zoledronic acid and to hypercalcemia, 7 months - Commentary",

author = "Loprinzi, {Charles L.}",

year = "2011",

month = jan,

language = "English (US)",

pages = "43",

journal = "Oncology Report",

issn = "1548-5323",

publisher = "Elsevier BV",

number = "JANUARY",

}

TY - JOUR

T1 - Denosumab stalls skeletal-related events in breast ca

T2 - Time to a first event was 5 months longer than with zoledronic acid and to hypercalcemia, 7 months - Commentary

AU - Loprinzi, Charles L.

PY - 2011/1

Y1 - 2011/1

UR - http://www.scopus.com/inward/record.url?scp=79951656057&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79951656057&partnerID=8YFLogxK

M3 - Comment/debate

AN - SCOPUS:79951656057

SN - 1548-5323

SP - 43

JO - Oncology Report

JF - Oncology Report

IS - JANUARY

ER -

Denosumab stalls skeletal-related events in breast ca: Time to a first event was 5 months longer than with zoledronic acid and to hypercalcemia, 7 months - Commentary

ASJC Scopus subject areas

Other files and links

Cite this